Agenda Clinical Hematology & Oncology 2021
Saturday, February 20, 2021
Topic: Benign Hematology
7 a.m.
Virtual Event Opens & View Exhibits
7:55 a.m.
Welcome & Educational Overview
8 a.m.
Basic Clinical Concepts in Thrombosis Diagnosis and Management: Refresher and 22 Teaching Points
Stephan Moll, MD
UNC School of Medicine
8:30 a.m.
HIT Clinical “Pearls”
Theodore (Ted) Earl Warkentin, MD, BSc
McMaster University
9 a.m.
Sickle Cell Disease and Hemoglobinopathies: 2021 Update for the Practicing Heme-Onc Healthcare Professional
Jane Little, MD
UNC School of Medicine
9:30 a.m.
Break, Networking & View Exhibits
9:45 a.m.
The Most Relevant Clinical Bleeding Developments of the Last 12 Months
Alice Ma, MD
UNC School of Medicine
10:15a.m.
Hematologic Aspects of COVID-19
Thomas Lee Ortel, MD, PhD
Duke University School of Medicine
10:45 a.m.
Hematological Problems of Pregnancy
John Kelton, MD
McMaster University
11:15 a.m.
Benign Hematology Panel
John Kelton, MD
Jane Little, MD
Alice Ma, MD
Stephan Moll, MD
Thomas Lee Ortel, MD, PhD
Theodore (Ted) Earl Warkentin, MD, BSc
11:45 a.m.
Break, Networking & View Exhibits
Topic: Malignant Hematology
12:45 p.m.
Tailoring Maintenance Therapy of Myeloma
Morie A. Gertz, MD
Mayo Clinic
1:15 p.m.
Diffuse Large Cell Lymphoma Subtypes and Treatment
Andrew D. Zelenetz, MD, PhD
Memorial Sloan Kettering Cancer Center
1:45 p.m.
Treatment Approaches to Mantle Cell Lymphoma
Luhua (Michael) Wang, MD
The University of Texas MD Anderson Cancer Center
2:15 p.m.
Break, Networking & View Exhibits
2:30 p.m.
Modern Treatment Options for CLL
Anthony Mato, MD, MSCE
Memorial Sloan Kettering Cancer Center
3 p.m.
AML in the Older Population
Hagop M. Kantarjian, MD
The University of Texas MD Anderson Cancer Center
3:30 p.m.
Therapeutic Updates for Follicular and Marginal Zone Lymphoma
Loretta J. Nastoupil, MD
The University of Texas MD Anderson Cancer Center
4 p.m.
Malignant Hematology Panel
Hagop M. Kantarjian, MD
Loretta J. Nastoupil, MD
Luhua (Michael) Wang, MD
4:30 p.m.
Adjourn
Sunday, February 21, 2021
Topic: Solid Tumor Oncology
6:45 a.m.
Virtual Event Opens & View Exhibits
7:40 a.m.
Welcome & Morning Announcements
7:45 a.m.
The Race Toward Equity: Increasing Racial Diversity in Cancer Research and Cancer Care
Lori J. Pearce, MD
University of Michigan
8:15a.m.
The Evolving Paradigm of Melanoma Treatment
Janice Mehnert, MD
NYU Langone Health
8:45 a.m.
Immunotherapy and Targeted Therapy in Upper GI Cancers
Sam Klempner, MD
Massachusetts General Hospital
9:15 a.m.
Break, Networking & View Exhibits
9:30 a.m.
How to Prioritize the Many Therapeutic Options for HER2+ Metastatic Breast Cancer
Debasish Tripathy, MD
The University of Texas MD Anderson Cancer Center
10 a.m.
Management of Non-Clear Cell RCC
Sumanta Kumar Pal, MD
City of Hope
10:30 a.m.
Updates in NSCLC with Emphasis on Front Line Therapy
Suresh S. Ramalingam, MD
Emory Winship Cancer Institute
11 a.m.
Solid Tumor Oncology Panel Part 1
Janice Mehnert, MD
Sam Klempner, MD
Suresh S. Ramalingam, MD
Debasish Tripathy, MD
11:30 a.m.
Break, Networking & View Exhibits
12:30 p.m.
Targeted Approaches in Sarcoma
Arun S. Singh, MD
University of California, Los Angeles Health
1 p.m.
Bernard Lee Schwartz Cancer Lectureship
Optimizing Immunotherapy for Metastatic Breast Cancer
Heather L. McArthur, MD, MPH
Cedars-Sinai Medical Center
1:30 p.m.
Practical Aspects of Novel Imaging Approaches in the Management of Prostate Cancer
Jeremie Calais, MD, MSc
University of California, Los Angeles
2 p.m.
Break, Networking & View Exhibits
2:15 p.m.
Update on Systemic Therapies for Thyroid Cancer
Eric J. Sherman, MD
Memorial Sloan Kettering Cancer Center
2:45 p.m.
New Approaches to Recurrent or Advanced Bladder Cancer
Dean F. Bajorin, MD
Memorial Sloan Kettering Cancer Center
3:15 p.m.
The Evolving Role of Liquid Biopsies
David R. Gandara, MD
University of California Davis Comprehensive Cancer
3:45 p.m.
Solid Tumor Oncology Panel
Jeremie Calais, MD, MSc
Heather L. McArthur, MD, MPH
Eric J. Sherman, MD
Arun S. Singh, MD
4:15 p.m.
Main Conference Final Adjournment
Please note: All times listed are Pacific Standard Time (PST)